Putting Patients at the Center of the Biosimilar Conversation

Christy M. Gamble, JD, DrPH, MPH, and Amanda Forys, MSPH, conclude the Peer ExchangeTM with a discussion of the importance of putting patients at the center of the biosimilar conversation.

 
March 14, 2018
View Text Version
x-button

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2018 Intellisphere, LLC. All Rights Reserved.